Preterm Labor Clinical Trial
Official title:
Cervical Cerclage for Singleton Pregnant on Vaginal Progesterone With Progressive Cervical Length Shortening
The aim of this study is to
Determine whether cerclage with vaginal progesterone will:
1. Reduce the overall spontaneous preterm birth rate.
2. Prolong pregnancy latency.
3. Improve neonatal outcome. Compared to vaginal progesterone only, in patients with
progressive cervical shortening.
Research question:
Does cervical cerclage reduce the overall spontaneous preterm births in patients with
progressive cervical shortening.
Research Hypothesis In this current study, the investigators hypothesize that cervical
cerclage reduces spontaneous preterm births in patients with progressive cervical shortening
on vaginal progesterone only.
A randomized controlled trial The study will be done in Ain Shams University Hospital
including women attending antenatal care clinic in Ain Shams University Hospital.
All patients entering the trial will be counselled and will sign a written consent explaining
the details of the trial. All the patients included in this study will undergo routine Fetal
anomaly scan at 18-24 weeks.Patients with cervical length < 20 mm in routine anomaly scan
will :
1. Receive vaginal progesterone suppositories 200 mg daily.. (All patients will be
continued with vaginal progesterone until 37 completed weeks or until they develop
preterm rupture of membrane or preterm delivery).
2. Undergo routine follow up of cervical length every 1 to 2 weeks. Patients with
progressive shortening of cervical length less than 10 mm during routine follow up, will
have the option of continuing vaginal progesterone daily (Progesterone 200 mg vaginal
suppositories) alone, or having cervical cerclage placed in addition to daily vaginal
progesterone.
In cerclage group: all patients will sign a written consent for approval of cervical
cerclage.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT06168149 -
The Relationship of Fetal Lung Elastography Values With the Development of Respiratory Distress in Cases of Preterm Labor
|
||
| Completed |
NCT02538718 -
Efficacy and Safety of MgSO4 as Tocolytics Compared to Ritodrine in Preterm Labor
|
N/A | |
| Not yet recruiting |
NCT05864066 -
Cyclin-dependent Kinase Inhibitor 2A (Placental Senescence Marker) on Labor-related Signals
|
||
| Terminated |
NCT03715530 -
Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women
|
N/A | |
| Recruiting |
NCT03638037 -
Correlation Between Maternal Vitamin D Level And Preterm Birth
|
||
| Recruiting |
NCT03992534 -
The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth
|
Phase 1 | |
| Withdrawn |
NCT03122704 -
Group B Streptococcus (GBS) Infection and in Preterm Labor Women Conceived Through IVF
|
N/A | |
| Completed |
NCT02536352 -
Effect of Supplementation of Fluoride on Maternal Periodontal Health, Preterm Delivery, and Perinatal Well-Being
|
Early Phase 1 | |
| Recruiting |
NCT01518816 -
Role of Serum Total Antioxidant Level in Preterm Labor
|
N/A | |
| Recruiting |
NCT04590677 -
Prediction of the Onset of Term and Preterm Labour
|
||
| Completed |
NCT03112018 -
Strengthening Facility-based Intrapartum/Immediate Newborn Care to Reduce Mortality of Preterm Infants in Migori County, Kenya and Busoga Region, Uganda
|
N/A | |
| Active, not recruiting |
NCT04301518 -
Prematurity Risk Assessment Combined With Clinical Interventions for Improving Neonatal outcoMEs
|
N/A | |
| Completed |
NCT03785795 -
Multichannel EMG Diagnosing True Preterm Labor
|
||
| Withdrawn |
NCT02351310 -
Effectiveness of ACS in Extreme Preemies
|
Phase 3 | |
| Not yet recruiting |
NCT01985594 -
Utrogestan Versus Nifedipine as Tocolysis for Preterm Labor: a Randomised Controlled Trial
|
Phase 2 | |
| Not yet recruiting |
NCT04532086 -
Uterocervical Angle and Preterm Labour
|
||
| Completed |
NCT04605172 -
Lockdown Impact on Spontaneous Premature Birth in a Level III NICU
|
||
| Recruiting |
NCT04417595 -
Investigating N-3 Fatty Acids to Prevent Neonatal Tobacco-related outcomeS
|
Phase 2 | |
| Completed |
NCT03923023 -
Impact of the PREEMI Package on Neonatal Mortality
|
||
| Recruiting |
NCT06157203 -
Labor Status Monitor for Diagnosing True vs False Labor in Preterm Patients
|